|
1
|
Sugiyama M and Atomi Y: Extrapancreatic
neoplasms occur with unusual frequency in patients with intraductal
papillary mucinous tumors of the pancreas. Am J Gastroenterol.
94:470–473. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yamaguchi K, Ohuchida J, Ohtsuka T, Nakano
K and Tanaka M: Intraductal papillary-mucinous tumor of the
pancreas concomitant with ductal carcinoma of the pancreas.
Pancreatology. 2:484–490. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bassi C, Sarr MG, Lillemoe KD and Reber
HA: Natural history of intraductal papillary mucinous neoplasms
(IPMN): Current evidence and implications for management. J
Gastrointest Surg. 12:645–650. 2008. View Article : Google Scholar
|
|
4
|
Choi MG, Kim SW, Han SS, Jang JY and Park
YH: High incidence of extrapancreatic neoplasms in patients with
intra-ductal papillary mucinous neoplasms. Arch Surg. 141:51–56;
discussion 56. 2006. View Article : Google Scholar
|
|
5
|
Eguchi H, Ishikawa O, Ohigashi H, Tomimaru
Y, Sasaki Y, Yamada T, Tsukuma H, Nakaizumi A and Imaoka S:
Patients with pancreatic intraductal papillary mucinous neoplasms
are at high risk of colorectal cancer development. Surgery.
139:749–754. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Baumgaertner I, Corcos O, Couvelard A,
Sauvanet A, Rebours V, Vullierme MP, Hentic O, Hammel P, Lévy P and
Ruszniewski P: Prevalence of extrapancreatic cancers in patients
with histologically proven intraductal papillary mucinous neoplasms
of the pancreas: A case-control study. Am J Gastroenterol.
103:2878–2882. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yoon WJ, Ryu JK, Lee JK, Woo SM, Lee SH,
Park JK, Kim YT and Yoon YB: Extrapancreatic malignancies in
patients with intraductal papillary mucinous neoplasm of the
pancreas: Prevalence, associated factors, and comparison with
patients with other pancreatic cystic neoplasms. Ann Surg Oncol.
15:3193–3198. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reid-Lombardo KM, Mathis KL, Wood CM,
Harmsen WS and Sarr MG: Frequency of extrapancreatic neoplasms in
intraductal papillary mucinous neoplasm of the pancreas:
Implications for management. Ann Surg. 251:64–69. 2010. View Article : Google Scholar
|
|
9
|
Larghi A, Panic N, Capurso G, Leoncini E,
Arzani D, Salvia R, Del Chiaro M, Frulloni L, Arcidiacono PG, Zerbi
A, et al: Prevalence and risk factors of extrapancreatic
malignancies in a large cohort of patients with intraductal
papillary mucinous neoplasm (IPMN) of the pancreas. Ann Oncol.
24:1907–1911. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kawakubo K, Tada M, Isayama H, Sasahira N,
Nakai Y, Yamamoto K, Kogure H, Sasaki T, Hirano K, Ijichi H, et al:
Incidence of extrapancreatic malignancies in patients with
intra-ductal papillary mucinous neoplasms of the pancreas. Gut.
60:1249–1253. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marchegiani G, Malleo G, D'Haese JG,
Wenzel P, Keskin M, Pugliese L, Borin A, Benning V, Nilsson L, Oruc
N, et al: Association between pancreatic intraductal papillary
mucinous neoplasms and extrapancreatic malignancies. Clin
Gastroenterol Hepatol. 13:1162–1169. 2015. View Article : Google Scholar
|
|
12
|
Tanaka M, Fernández-del Castillo C, Adsay
V, Chari S, Falconi M, Jang JY, Kimura W, Levy P, Pitman MB,
Schmidt CM, et al International Association of Pancreatology:
International consensus guidelines 2012 for the management of IPMN
and MCN of the pancreas. Pancreatology. 12:183–197. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
International Rules for Multiple Primary
Cancers ICD-O. Third Edit. (Internal Report). Lyon: IARC; 2004
|
|
14
|
Matsuda T, Marugame T, Kamo K, Katanoda K,
Ajiki W and Sobue T; Japan Cancer Surveillance Research Group:
Cancer incidence and incidence rates in Japan in 2003: Based on
data from 13 population-based cancer registries in the Monitoring
of Cancer Incidence in Japan (MCIJ) Project. Jpn J Clin Oncol.
39:850–858. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
R Development Core Team: R: A language and
environment for statistical computing. R Foundation for Statistical
Computing; 2011
|
|
16
|
Sullivan KM, Dean A and Soe MM: OpenEpi: A
web-based epidemiologic and statistical calculator for public
health. Public Health Rep. 124:471–474. 2009.PubMed/NCBI
|
|
17
|
World Medical A; World Medical
Association: World Medical Association Declaration of Helsinki:
Ethical principles for medical research involving human subjects.
JAMA. 310:2191–2194. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tabuchi T, Ito Y, Ioka A, Miyashiro I and
Tsukuma H: Incidence of metachronous second primary cancers in
Osaka, Japan: Update of analyses using population-based cancer
registry data. Cancer Sci. 103:1111–1120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen T, Fallah M, Jansen L, Castro FA,
Krilavicuite A, Katalinic A, Eisemann N, Emrich K, Holleczek B,
Geiss K, et al GEKID Cancer Survival Working Group: Distribution
and risk of the second discordant primary cancers combined after a
specific first primary cancer in German and Swedish cancer
registries. Cancer Lett. 369:152–166. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee SY, Choi DW, Jang KT, Lee KT, Choi SH,
Heo JS, Lee JK, Paik SW and Rhee JC: High expression of
intestinal-type mucin (MUC2) in intraductal papillary mucinous
neoplasms coexisting with extrapancreatic gastrointestinal cancers.
Pancreas. 32:186–189. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hong SM, Omura N, Vincent A, Li A, Knight
S, Yu J, Hruban RH and Goggins M: Genome-wide CpG island profiling
of intraductal papillary mucinous neoplasms of the pancreas. Clin
Cancer Res. 18:700–712. 2012. View Article : Google Scholar :
|
|
22
|
Almoguera C, Shibata D, Forrester K,
Martin J, Arnheim N and Perucho M: Most human carcinomas of the
exocrine pancreas contain mutant c-K-ras genes. Cell. 53:549–554.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schönleben F, Qiu W, Ciau NT, Ho DJ, Li X,
Allendorf JD, Remotti HE and Su GH: PIK3CA mutations in intraductal
papillary mucinous neoplasm/carcinoma of the pancreas. Clin Cancer
Res. 12:3851–3855. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
von Figura G, Fukuda A, Roy N, Liku ME,
Morris Iv JP, Kim GE, Russ HA, Firpo MA, Mulvihill SJ, Dawson DW,
et al: The chromatin regulator Brg1 suppresses formation of
intraductal papillary mucinous neoplasm and pancreatic ductal
adenocarcinoma. Nat Cell Biol. 16:255–267. 2014. View Article : Google Scholar : PubMed/NCBI
|
